26 May 2026Open access
Integrating network pharmacology with ex-vivo analysis to assess the effect of IL-2 in halting breast cancer: involvement of Treg/CTLA-4/Blimp-1/caspase-3Publisher siteScientific Reports, Cancer Immunotherapy and Biomarkers
UniversitiesSherihan Salaheldin Abdelhamid Ibrahim
Active, last published 2026
In phytochemical studies and bioactivities
Sherihan Salaheldin Abdelhamid
Ibrahim
Scholar“Research focused on Phytochemical Studies and Bioactivities and adjacent fields.”
Pharos University in Alexandria
Claim Your Profile14
H-index
372
Citations
Sherihan has not officially claimed their profile. If you are Sherihan, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
herihan Salaheldin Abdelhamid Ibrahim is a researcher working on Phytochemical Studies and Bioactivities. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Sherihan's work has been cited 372 times across 5 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Phytochemical Studies and Bioactivities×3Osteoarthritis Treatment and Mechanisms×2Helicobacter pylori-related gastroenterology studies×2Psoriasis: Treatment and Pathogenesis×2Peroxisome Proliferator-Activated Receptors×2
04 · Where I am
Affiliations
Affiliation on published researchPharos University in AlexandriaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
13 works1 Aug 2025Open access1cites
Gastroprotective effect of Arabincoside B isolated from Caralluma arabica against ethanol-induced gastric injury via modulating oxidative stress/SP/NK-1R/NF-κB loopPublisher siteInflammopharmacology, Phytochemistry and Bioactive Compounds
12 Sept 2024Open access10cites
Tetrandrine ameliorated atherosclerosis in vitamin D3/high cholesterol diet-challenged rats via modulation of miR-34a and Wnt5a/Ror2/ABCA1/NF-kB trajectoryPublisher siteScientific Reports, Berberine and alkaloids research
12 Jun 2024Open access10cites
The gastroprotective effect of Yucca filamentosa standardized crude leaves extract versus its nano-cubosomal formulation in ethanol-induced gastric injuryPublisher siteInternational Immunopharmacology, Food Quality and Safety Studies
8 May 20249cites
Boswellic acid and apigenin alleviate methotrexate-provoked renal and hippocampal alterations in rats: Targeting autophagy, NOD-2/NF-κB/NLRP3, and connexin-43Publisher siteInternational Immunopharmacology, Pharmacological Effects of Medicinal Plants
21 Apr 2024Open access14cites
A drug repurposing approach of Atorvastatin calcium for its antiproliferative activity for effective treatment of breast cancer: In vitro and in vivo assessmentPublisher siteInternational Journal of Pharmaceutics X, Cancer, Lipids, and Metabolism
19 Mar 2024Open access14cites
Enhancing collagen based nanoemulgel for effective topical delivery of Aceclofenac and Citronellol oil: Formulation, optimization, in-vitro evaluation, and in-vivo osteoarthritis study with a focus on HMGB-1/RAGE/NF-κB pathway, Klotho, and miR-499aPublisher siteDrug Delivery and Translational Research, Osteoarthritis Treatment and Mechanisms
30 Dec 2023Open access
Correction: L-Carnitine augments probenecid anti-inflammatory effect in monoiodoacetate-induced knee osteoarthritis in rats: involvement of miRNA-373/P2X7/NLRP3/NF-κB milieuPublisher siteInflammopharmacology, Osteoarthritis Treatment and Mechanisms
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Sherihan?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you